Assessing Posture and ROM With PhysioMaster in Stroke Patients
ConditionStroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-70
SponsorIstinye University
About this trial
The smartphone application named PhysioMaster is an easy-to-use, accessible, and freely available application. Although it has been used in several previous studies, no validity or reliability study has yet been conducted in patients with stroke. Therefore, the aim of this study is to investigate the validity and reliability of the PhysioMaster smartphone application in patients with stroke.
Accordingly, our hypotheses are as follows:
* H0: The PhysioMaster application is not a valid and reliable measurement tool for the assessment of posture and range of motion in patients with stroke. * H1: The PhysioMaster application is a valid and reliable measurement tool for the assessment of posture and range of motion in patients with stroke. Participants will not take any intervention.
Participants will be evaluated in terms of posture and range of motion by using PhysioMaster, Universal Goniometer and PostureScreen Mobile. During the first-day assessment, physiotherapists A and B will complete both the PhysioMaster application assessments and all other evaluations on the same patient without seeing each other's assessment scores. In order to evaluate the test-retest reliability of the application, physiotherapist A will repeat the assessments on Physiomaster on the same patient after 3 days.
Eligibility criteria
Qualifiers
Presence of hemiplegia caused solely by stroke
Being older than 40 years and younger than 70 years of age
At least 6 months have passed since the stroke
Ability to maintain independent standing for at least 1 minute
Disqualifiers
Presence of any neurological diagnosis other than stroke
History of orthopedic surgery within the last 6 months
Presence of concomitant orthopedic trauma
Presence of spasticity graded 3 or higher according to the Modified Ashworth Scale (MAS)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov